Cargando…
GABRA1 and GABRB2 Polymorphisms are Associated with Propofol Susceptibility
PURPOSE: To explore the effect of gene polymorphisms of propofol GABA(A) receptor and metabolic enzyme on drug susceptibility during the induction period of general anesthesia. PATIENTS AND METHODS: A total of 294 female patients aged 18–55 years, ASA I–II, who underwent hysteroscopy with intravenou...
Autores principales: | Zeng, Youjie, Cao, Si, Chen, Minghua, Fang, Chao, Ouyang, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841664/ https://www.ncbi.nlm.nih.gov/pubmed/35173461 http://dx.doi.org/10.2147/PGPM.S348170 |
Ejemplares similares
-
CYP2A6 and GABRA2 Gene Polymorphisms are Associated With Dexmedetomidine Drug Response
por: Fang, Chao, et al.
Publicado: (2022) -
The Effects of Gene Variations of GABRA2, GABRB1, GABRG2, GAD1 and SLC1A3 on Patients with Propofol During Anesthesia Induction
por: Zhang, Lingyi, et al.
Publicado: (2021) -
Dravet syndrome-associated mutations in GABRA1, GABRB2 and GABRG2 define the genetic landscape of defects of GABA(A) receptors
por: Hernandez, Ciria C, et al.
Publicado: (2021) -
Molecular and clinical descriptions of patients with GABA(A)
receptor gene variants (
GABRA1, GABRB2, GABRB3, GABRG2
): A cohort study, review of literature, and genotype–phenotype correlation
por: Maillard, Pierre‐Yves, et al.
Publicado: (2022) -
Correction to: Dravet syndrome-associated mutations in GABRA1, GABRB2 and GABRG2 define the genetic landscape of defects of GABA(A) receptors
Publicado: (2022)